Close Menu

Rheonix

The CDC says that the number of people in the US who have been infected with diseases carried by mosquitoes, ticks, and flea bites have more than tripled in recent years.

The researchers built a combination nucleic acid-antibody test for the disease using an approach they said could be generally useful for rapid test development.

Rheonix has won an administrative supplement to an existing SBIR grant to develop the Zika test using its CARD cartridge and Encompass Optimum platform.

The firm's dual assay for host antigen to HIV as well as viral RNA was described in a proof-of-principle study earlier this year. 

Rheonix Raises $28.6M

The Ithaca, New York-based firm will use the financing to ramp up commercialization of its molecular diagnostic testing platforms.

The firm is aiming at in vitro diagnostics, applied markets, and next-generation sequencing sample preparation.

The Phase II grant will provide the company with funding to develop a commercial-ready version of the test.

The fully automated self-confirming assay will simultaneously detect HIV/AIDS antibodies and viral RNA in a single specimen.

HandyLab has been awarded

Pages

Australia will not be regulating gene editing of plants, animals, and human cell lines as long as no new genetic material is incorporated, reports Nature News.

The Washington Post reports that the US Department of Agriculture told its researchers to label peer-reviewed articles as "preliminary" work.

Researchers have sequenced the genomes of both the coast redwood and the giant sequoia, according to the San Francisco Chronicle.

In PNAS this week: study of epigenetic patterns in mammalian eggs, clonal expansion patterns in CD8+ T cells, and more.